X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7570) 7570
Book Review (1356) 1356
Publication (684) 684
Newsletter (590) 590
Government Document (104) 104
Book Chapter (79) 79
Conference Proceeding (34) 34
Book / eBook (24) 24
Newspaper Article (24) 24
Dissertation (16) 16
Magazine Article (15) 15
Web Resource (8) 8
Reference (7) 7
Trade Publication Article (2) 2
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (6113) 6113
humans (5804) 5804
neurofibromatosis (3440) 3440
female (2850) 2850
male (2809) 2809
neurofibromatosis 1 - genetics (2075) 2075
adult (1873) 1873
child (1603) 1603
adolescent (1344) 1344
genetics & heredity (1330) 1330
mutation (1284) 1284
middle aged (1162) 1162
animals (1136) 1136
tumors (1095) 1095
neurofibromatosis 1 - complications (1085) 1085
neurofibromatosis type 1 (1048) 1048
research (1003) 1003
oncology (960) 960
child, preschool (947) 947
genetic aspects (928) 928
neurofibromatosis 1 - pathology (922) 922
clinical neurology (894) 894
cancer (888) 888
nf1 (856) 856
neurofibromatosis 1 - diagnosis (822) 822
children (771) 771
mice (751) 751
neurofibromatosis type-1 (748) 748
pediatrics (665) 665
gene (645) 645
genes, neurofibromatosis 1 (645) 645
surgery (599) 599
magnetic resonance imaging (587) 587
diagnosis (584) 584
aged (582) 582
infant (575) 575
neurosciences (563) 563
mutations (545) 545
phenotype (526) 526
abridged index medicus (520) 520
analysis (520) 520
neurofibromin 1 - genetics (471) 471
genes (452) 452
pathology (452) 452
biochemistry & molecular biology (442) 442
care and treatment (441) 441
genetics (441) 441
cell biology (440) 440
expression (421) 421
pedigree (421) 421
article (405) 405
young adult (403) 403
molecular sequence data (401) 401
base sequence (400) 400
neurofibromatosis 1 (391) 391
risk factors (389) 389
neurofibromatosis 2 - genetics (382) 382
medicine & public health (375) 375
nf1 gene (369) 369
recklinghausen's disease (365) 365
neoplasms (354) 354
vonrecklinghausen neurofibromatosis (347) 347
congenital, hereditary, and neonatal diseases and abnormalities (345) 345
diagnosis, differential (339) 339
health aspects (331) 331
neurofibromin 1 (328) 328
type-1 (319) 319
proteins (318) 318
medical research (313) 313
dna mutational analysis (311) 311
identification (307) 307
dermatology (302) 302
signal transduction (300) 300
immunohistochemistry (299) 299
reports (299) 299
nervous system diseases (296) 296
gene mutations (293) 293
polymerase chain reaction (293) 293
disease (287) 287
cells (283) 283
nf2 (278) 278
growth (276) 276
retrospective studies (269) 269
neurology (266) 266
neurofibromatosis 1 - metabolism (265) 265
neurofibroma (263) 263
gene expression (260) 260
neurofibromatosis 1 - physiopathology (249) 249
prognosis (249) 249
medicine (243) 243
medicine, experimental (243) 243
patients (242) 242
case report (239) 239
neurofibromatosis type 2 (235) 235
ras (235) 235
disease models, animal (233) 233
neurofibromatosis type-2 (232) 232
nerve sheath tumors (230) 230
genes, neurofibromatosis 2 (228) 228
genetic disorders (223) 223
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7895) 7895
French (143) 143
German (98) 98
Spanish (48) 48
Japanese (43) 43
Polish (32) 32
Russian (24) 24
Italian (17) 17
Korean (17) 17
Chinese (12) 12
Hungarian (12) 12
Portuguese (12) 12
Dutch (8) 8
Croatian (7) 7
Czech (7) 7
Hebrew (6) 6
Danish (5) 5
Romanian (5) 5
Swedish (4) 4
Turkish (4) 4
Finnish (3) 3
Norwegian (3) 3
Persian (2) 2
Bengali (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Patch, Ann-Marie and Christie, Elizabeth L and Etemadmoghadam, Dariush and Garsed, Dale W and George, Joshy and Fereday, Sian and Nones, Katia and Cowin, Prue and Alsop, Kathryn and Bailey, Peter J and Kassahn, Karin S and Newell, Felicity and Quinn, Michael C.J and Kazakoff, Stephen and Quek, Kelly and Wilhelm-Benartzi, Charlotte and Curry, Ed and Leong, Huei San and Hamilton, Anne and Mileshkin, Linda and Au-Yeung, George and Kennedy, Catherine and Hung, Jillian and Chiew, Yoke-Eng and Harnett, Paul and Friedlander, Michael and Quinn, Michael and Pyman, Jan and Cordner, Stephen and O'Brien, Patricia and Leditschke, Jodie and Young, Greg and Strachan, Kate and Waring, Paul and Azar, Walid and Mitchell, Chris and Traficante, Nadia and Hendley, Joy and Thorne, Heather and Shackleton, Mark and Miller, David K and Arnau, Gisela Mir and Tothill, Richard W and Holloway, Timothy P and Semple, Timothy and Harliwong, Ivon and Nourse, Craig and Nourbakhsh, Ehsan and Manning, Suzanne and Idrisoglu, Senel and Bruxner, Timothy J. C and Christ, Angelika N and Poudel, Barsha and Holmes, Oliver and Anderson, Matthew and Leonard, Conrad and Lonie, Andrew and Hall, Nathan and Wood, Scott and Taylor, Darrin F and Xu, Qinying and Lynn Fink, J and Waddell, Nick and Drapkin, Ronny and Stronach, Euan and Gabra, Hani and Brown, Robert and Jewell, Andrea and Nagaraj, Shivashankar H and Markham, Emma and Wilson, Peter J and Ellul, Jason and McNally, Orla and Doyle, Maria A and Vedururu, Ravikiran and Stewart, Collin and Lengyel, Ernst and Pearson, John V and Waddell, Nicola and Defazio, Anna and Grimmond, Sean M and Bowtell, David D. L and Australian Ovarian Canc Study Grp and Australian Ovarian Cancer Study Group and The Australian Ovarian Cancer Study Group
Nature, ISSN 0028-0836, 05/2015, Volume 521, Issue 7553, pp. 489 - 494
Journal Article
Journal of Neurosurgery: Spine, ISSN 1547-5654, 01/2019, Volume 30, Issue 1, pp. 126 - 132
OBJECTIVE C2 nerve root neurofibromas have been reported frequently in patients with neurofibromatosis type 1 (NF1), although their genetic and imaging... 
Spinal neurofibromas | Oncology | Neurofibromatosis type 1 | Spinal neurofibromatosis | Von Recklinghausen’s disease | SURGERY | DIAGNOSIS | SERIES | ROOT | SURGICAL-MANAGEMENT | PROLIFERATION | NATURAL-HISTORY | spinal neurofibromas | oncology | CLINICAL NEUROLOGY | neurofibromatosis type 1 | NF1 | Von Recklinghausen's disease | spinal neurofibromatosis | NERVE SHEATH TUMORS
Journal Article
Nature, ISSN 0028-0836, 05/2017, Volume 545, Issue 7653, pp. 175 - 180
Melanoma of the skin is a common cancer only in Europeans, whereas it arises in internal body surfaces (mucosal sites) and on the hands and feet (acral sites)... 
TERT PROMOTER MUTATIONS | UVEAL MELANOMA | SEQUENCE DATA | MULTIDISCIPLINARY SCIENCES | RECURRENT MUTATIONS | FREQUENT SOMATIC MUTATIONS | MALIGNANT-MELANOMA | GENERAL FRAMEWORK | CANCER GENOMES | ACTIVATING MUTATIONS | DRIVER MUTATIONS | Membrane Proteins - genetics | Humans | X-linked Nuclear Protein | Phosphoproteins - genetics | RNA Splicing Factors - genetics | Mutation - genetics | Genes, p16 | Genome, Human - genetics | Tumor Suppressor Protein p53 - genetics | Ultraviolet Rays - adverse effects | Telomerase - genetics | Signal Transduction - drug effects | GTP Phosphohydrolases - genetics | Melanoma - genetics | Proto-Oncogene Proteins B-raf - genetics | Mitogen-Activated Protein Kinases - genetics | Neurofibromatosis 1 - genetics | Melanoma - classification | Nuclear Proteins - genetics | DNA Helicases - genetics | Telomere - genetics | Genetic research | Genetic aspects | Genomes | Research | Melanoma | Pathogenesis | Copy number | Mucosa | p53 Protein | Radiation | Security | Epidemiology | Metastases | Reproduction (copying) | Coding | Mismatch repair | Clusters | Eye (anatomy) | Fellowships | Deoxyribonucleic acid--DNA | Medical research | Breakpoints | Radiation effects | MAP kinase | Exposure | Sun | Amplification | Bridges | Pathology | Ultraviolet radiation | Mutagenesis | Computation | Skin | Mutation | Internet | Aberration | Biotechnology | Genes | DNA damage | Carcinogens | Infrastructure | Signatures | Health | U.V. radiation | Inversions | Foldback | Data processing | Energy policy | Readers | Deamination | Protein kinase | Cell lines | Gene mapping | Tumors | Cancer | Index Medicus | Biological Science | 60 APPLIED LIFE SCIENCES
Journal Article
Journal Article
Nature, ISSN 0028-0836, 2014, Volume 514, Issue 7521, pp. 247 - 251
The polycomb repressive complex 2 (PRC2) exerts oncogenic effects in many tumour types(1). However, loss-of-function mutations in PRC2 components occur in a... 
SUPPRESSOR | GENE | MULTIDISCIPLINARY SCIENCES | MICE | NF1 MICRODELETION PATIENTS | MUTATIONS | BET BROMODOMAIN INHIBITION | CANCER | TUMORS | NEUROFIBROMATOSIS TYPE-1 | EZH2 | Chromatin - metabolism | Transcription, Genetic - drug effects | Polycomb Repressive Complex 2 - genetics | Humans | Transcription Factors - deficiency | ras Proteins - metabolism | Neurofibromin 1 - deficiency | Glioma - genetics | Neoplasms - genetics | Melanoma - genetics | Tumor Suppressor Proteins - deficiency | Glioma - pathology | Nerve Sheath Neoplasms - pathology | Nuclear Proteins - deficiency | Tumor Suppressor Proteins - genetics | Epigenesis, Genetic - drug effects | Cell Death - drug effects | Gene Expression Regulation, Neoplastic - drug effects | Nuclear Proteins - genetics | Chromatin - drug effects | Nerve Sheath Neoplasms - drug therapy | Disease Models, Animal | Triazoles - therapeutic use | Nerve Sheath Neoplasms - genetics | Tumor Suppressor Proteins - metabolism | Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors | ras Proteins - antagonists & inhibitors | Nuclear Proteins - metabolism | Transcription Factors - antagonists & inhibitors | Melanoma - pathology | Transcription Factors - genetics | Azepines - therapeutic use | Neoplasms - drug therapy | Azepines - pharmacology | Transcription Factors - metabolism | Triazoles - pharmacology | Animals | Polycomb Repressive Complex 2 - deficiency | Melanoma - drug therapy | Nuclear Proteins - antagonists & inhibitors | Mice | Neoplasms - pathology | Polycomb Repressive Complex 2 - metabolism | Chromatin - genetics | Neurofibromin 1 - genetics | Glioma - drug therapy | Epigenetic inheritance | Ras genes | Genetic transcription | Research | Gliomas | Studies | Mutation | Genes | Tumors | Defects | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2005, Volume 23, Issue 34, pp. 8812 - 8818
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 8/2014, Volume 111, Issue 31, pp. 11473 - 11478
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 01/2013, Volume 123, Issue 1, pp. 335 - 339
Children with neurofibromatosis type 1 (NF1) are predisposed to juvenile myelomonocytic leukemia (JMML), an aggressive myeloproliferative neoplasm (MPN) that... 
HEMATOPOIETIC-CELLS | INACTIVATION | MEDICINE, RESEARCH & EXPERIMENTAL | PROGENITOR | GENE | RAS | RESISTANCE | Mitogen-Activated Protein Kinase Kinases - genetics | Diphenylamine - pharmacology | Leukemia, Myelomonocytic, Juvenile - metabolism | Humans | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Child, Preschool | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Erythropoiesis - drug effects | Hematopoiesis, Extramedullary - genetics | Neurofibromin 1 | Leukemia, Myelomonocytic, Juvenile - etiology | Cell Differentiation - genetics | Diphenylamine - analogs & derivatives | Mitogen-Activated Protein Kinase Kinases - metabolism | Mice, Mutant Strains | Benzamides - pharmacology | Leukemia, Myelomonocytic, Juvenile - genetics | Neurofibromatosis 1 - genetics | Child | Hematopoiesis, Extramedullary - drug effects | Disease Models, Animal | Erythropoiesis - genetics | Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors | Animals | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - etiology | Cell Differentiation - drug effects | Neurofibromatosis 1 - drug therapy | Neurofibromatosis 1 - complications | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism | Cell Proliferation - drug effects | Mice | Leukemia, Myelomonocytic, Juvenile - drug therapy | Gene mutations | Physiological aspects | Genetic aspects | Research | Health aspects | Myeloproliferative disorders | Risk factors | Mitogen-activated protein kinases | Index Medicus | Abridged Index Medicus | Brief Report
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 01/2013, Volume 123, Issue 1, pp. 340 - 347
Neurofibromatosis type 1 (NF1) patients develop benign neurofibromas and malignant peripheral nerve sheath tumors (MPNST). These incurable peripheral nerve... 
MEDICINE, RESEARCH & EXPERIMENTAL | SIGNALING PATHWAYS | PLEXIFORM NEUROFIBROMAS | GENOMIC ANALYSES | THERAPEUTIC TARGET | NF1 | SCHWANN-CELLS | HYPERACTIVE RAS | CANCER | NERVE SHEATH TUMORS | PREVIOUSLY TREATED PATIENTS | Neoplasm Transplantation | Mitogen-Activated Protein Kinase Kinases - genetics | Diphenylamine - pharmacology | Humans | Child, Preschool | Male | Transplantation, Heterologous | Extracellular Signal-Regulated MAP Kinases - metabolism | raf Kinases - metabolism | Extracellular Signal-Regulated MAP Kinases - genetics | Oncogene Protein p21(ras) - metabolism | Diphenylamine - analogs & derivatives | Mitogen-Activated Protein Kinase Kinases - metabolism | Peripheral Nervous System Neoplasms - enzymology | Mice, Mutant Strains | Female | Benzamides - pharmacology | Neurofibromatosis 1 - genetics | Peripheral Nervous System Neoplasms - pathology | raf Kinases - genetics | Child | Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors | Peripheral Nervous System Neoplasms - drug therapy | Transcriptome - drug effects | Transcriptome - genetics | Xenograft Model Antitumor Assays | Neurofibromatosis 1 - enzymology | Neurofibromatosis 1 - pathology | Animals | Neurofibromatosis 1 - drug therapy | Mice | Peripheral Nervous System Neoplasms - genetics | Oncogene Protein p21(ras) - genetics | Physiological aspects | Causes of | Neural stimulation | Enzyme inhibitors | Properties | Neurofibromatosis | Index Medicus | Abridged Index Medicus
Journal Article